Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Hvh-2930 | 3034605-72-3 | 96.5% | 488.62 | C29H36N4O3 | 10 MG
Supplier: Medchemexpress LLC HY16178110MG
HVH-2930 is a small-molecule inhibitor of heat shock protein 90 (HSP90) used for preclinical research into HER2-positive breast cancer. It has demonstrated activity against trastuzumab-sensitive and -resistant cell lines and shows antitumor efficacy and favorable pharmacokinetics in animal models.
- Inhibits heat shock protein 90 (HSP90) in cellular assays.
- Demonstrated activity in trastuzumab-sensitive and -resistant HER2-positive breast cancer cell lines.
- Shown antitumor efficacy and favorable pharmacokinetic properties in mouse models.
- High purity (~96.5%) suitable for research applications.
- Solid, light yellow to yellow appearance; stable under recommended storage conditions.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?